ABSTRACT
New psychoactive substances (NPS) sometimes referred to as “legal highs” or “designer drugs” are psychotropic materials that mimic the effects of other banned illicit drugs but are not always controlled under drug legislation. NPS are typically marketed as “not for human consumption” and are instead labelled and sold as research chemicals in Poland to avoid legislative controls. One of the main NPS classes are hallucinogens. The present paper aims at providing an overview of two groups of psychedelic drugs – lysergamides and tryptamines, and determining their legislation status in Poland. Psychodysleptics have always been of interest to people who want to experiment with their senses and boundaries. They may show beneficial effects which, from a medical point of view indicate the possibility of using them in therapies. NPS that have been described in this paper: 1-Propionyl-d-lysergic acid diethylamide (1P-LSD), 6-Allyl-6-nor-lysergic acid diethylamide (AL-LAD), 6-Ethyl-6-nor-lysergic acid diethylamide (ETH-LAD), 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET), 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT).
Support the magazine and subscribe to the content
This is premium stuff. Subscribe to read the entire article.
